89 related articles for article (PubMed ID: 28458622)
1. Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells.
Ndolo KM; Park KR; Lee HJ; Yoon KB; Kim YC; Han SY
Immune Netw; 2017 Apr; 17(2):110-115. PubMed ID: 28458622
[TBL] [Abstract][Full Text] [Related]
2. Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells.
Chung HJ; Park KR; Lee HJ; Lee J; Kim JH; Kim YC; Han SY
Biochem Biophys Res Commun; 2015 Jun; 461(4):605-11. PubMed ID: 25912878
[TBL] [Abstract][Full Text] [Related]
3. Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819.
Kim WH; Jeong P; Kim SW; Cho H; Lee JM; Seo S; Shen H; Ahn Y; Jung DW; Kim YC; Williams DR
Data Brief; 2019 Aug; 25():104373. PubMed ID: 31489353
[TBL] [Abstract][Full Text] [Related]
4. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
Suzuki T; Miyazaki K; Kita K; Ochi T
Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
[TBL] [Abstract][Full Text] [Related]
5. Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with
Ndolo KM; An SJ; Park KR; Lee HJ; Yoon KB; Kim YC; Han SY
Biomol Ther (Seoul); 2019 Mar; 27(2):216-221. PubMed ID: 30060294
[TBL] [Abstract][Full Text] [Related]
6. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
[TBL] [Abstract][Full Text] [Related]
7. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation.
Goto H; Yasui Y; Nigg EA; Inagaki M
Genes Cells; 2002 Jan; 7(1):11-7. PubMed ID: 11856369
[TBL] [Abstract][Full Text] [Related]
8. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.
Walsby E; Walsh V; Pepper C; Burnett A; Mills K
Haematologica; 2008 May; 93(5):662-9. PubMed ID: 18367484
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Fallahi P; Mian C; Barollo S; Catania A; Morrone S; Tartaglia F; Mascagni D; Coccaro C; Pepe M; Filippini A; D'Armiento M; Ulisse S
J Biol Regul Homeost Agents; 2015; 29(4):793-803. PubMed ID: 26753639
[TBL] [Abstract][Full Text] [Related]
10. Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.
Tuccilli C; Baldini E; Prinzi N; Morrone S; Sorrenti S; Filippini A; Catania A; Alessandrini S; Rendina R; Coccaro C; D'Armiento M; Ulisse S
Endocrine; 2016 May; 52(2):287-95. PubMed ID: 26215279
[TBL] [Abstract][Full Text] [Related]
11. A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity.
Kim WH; Jeong P; Kim SW; Cho H; Lee JM; Seo S; Shen H; Ahn Y; Jung DW; Kim YC; Williams DR
Bioorg Med Chem; 2019 Jul; 27(13):2923-2934. PubMed ID: 31147141
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro.
Tomita M; Tanaka Y; Mori N
Int J Cancer; 2010 Oct; 127(7):1584-94. PubMed ID: 20091867
[TBL] [Abstract][Full Text] [Related]
13. Aurora kinase is required for chromosome segregation in tobacco BY-2 cells.
Kurihara D; Matsunaga S; Kawabe A; Fujimoto S; Noda M; Uchiyama S; Fukui K
Plant J; 2006 Nov; 48(4):572-80. PubMed ID: 17087760
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor.
Xie F; Zhu H; Zhang H; Lang Q; Tang L; Huang Q; Yu L
Eur J Med Chem; 2015 Jan; 89():310-9. PubMed ID: 25462247
[TBL] [Abstract][Full Text] [Related]
15. S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line.
Li J; Lang Q; Zhang H; Huang Q; Yu L
Biotechnol Lett; 2013 Jun; 35(6):853-60. PubMed ID: 23443212
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal activation of aurora C in rat pineal gland: its role in the norepinephrine-induced phosphorylation of histone H3 and gene expression.
Price DM; Kanyo R; Steinberg N; Chik CL; Ho AK
Endocrinology; 2009 May; 150(5):2334-41. PubMed ID: 19116339
[TBL] [Abstract][Full Text] [Related]
17. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
[TBL] [Abstract][Full Text] [Related]
18. Aurora Kinase B Phosphorylates Histone H3.3 at Serine 31 during Mitosis in Mammalian Cells.
Li M; Dong Q; Zhu B
J Mol Biol; 2017 Jun; 429(13):2042-2045. PubMed ID: 28137420
[TBL] [Abstract][Full Text] [Related]
19. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis.
Zeitlin SG; Shelby RD; Sullivan KF
J Cell Biol; 2001 Dec; 155(7):1147-57. PubMed ID: 11756469
[TBL] [Abstract][Full Text] [Related]
20. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Catania A; Moretti C; Mocini R; Carbotta G; Morrone S; Persechino S; Redler A; De Antoni E; D' Armiento M; Ulisse S
J Biol Regul Homeost Agents; 2013; 27(3):705-15. PubMed ID: 24152827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]